MacDermid invites Merrill to evaluate buyout

MacDermid, an NYSE-listed specialty chemicals maker, has brought in Merrill Lynch to advise it on a proposed $1bn (€789m) private equity-backed managment buyout.

MacDermid said today that a special committee of the board will "weigh the MBO and any other alternatives that may be available to the company."

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump